Rangwala Reshma

Rangwala Reshma is listed in filings as EVP & Chief Medical Officer at Karyopharm Therapeutics Inc.. This profile follows SEC Form 4 activity through May 15, 2026, including sale activity. Recent filings connect the profile to Karyopharm Therapeutics Inc. (KPTI). The current snapshot covers public activity from Mar 4, 2025 to May 15, 2026. Reported amounts are shown as $3.9K to $47.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.